CClinicalTrials.gg
CompletedNCT02033005Updated Nov 15, 2022Results posted

Newborn Feeding and Infant Phenotype

An observational study in Breast Feeding, sponsored by Imperial College London. Completed at 1 site in United Kingdom. Open to participants aged Up to 4 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-15.

Sponsored by Imperial College London · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
124
Ages
Up to 4 Weeks
Sex
All
01

Study summary

Breast feeding is believed to be beneficial to long-term health but how these effects are mediated is unknown. I suggest that this may be through effects on body composition and metabolism.

I will compare adipose tissue and liver fat deposition in healthy, full term breast and formula fed infants babies shortly after birth and around 12 weeks.

02

Conditions studied

  • Breast Feeding

Keywords

  • Body Composition
  • Adipose Tissue
  • Intrahepatocellular Lipid
  • Infant
  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
03

In context

Lead sponsor

Imperial College London is the lead sponsor of 824 studies on the registry; 178 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 4 Weeks
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy, full term, appropriate weight for gestational age infants recruited on the postnatal ward at Chelsea and Westminster Hospital, London, UK.

Inclusion criteria

  • Healthy baby
  • Term baby
  • Appropriate weight for gestational age (UK - WHO 2009 growth charts)

Exclusion criteria

Exclusion Criteria:

  • Infants of diabetic mothers
  • Infants of smokers
  • Infants fed non-commercial or non-cows milk based infant formulae
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
124 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Breastfed infants

    \>80% of feeds consisting of breast milk at both scanning points

  • Formula-fed infants

    \>80% of feeds consisting of formula milk at both scanning points

  • Mixed-fed infants

    20%-80% of feeds consisting of breast milk.

06

What researchers measure

Primary outcomes

  1. Change in Total Adipose Tissue Volume

    Difference in total adipose tissue volume, measured using whole body magnetic resonance imaging.

    Time frame: Between birth and 6-12 weeks age

Secondary outcomes

  1. Change in Regional Adipose Tissue Distribution Compared to Breastfed Infants.

    Change in regional adipose tissue distribution (ratio of internal abdominal to total subcutaneous abdominal adipose tissue) measured using whole body magnetic resonance imaging

    Time frame: Between birth and 6-12 weeks age

  2. Change in Intrahepatocellular Lipid Compared to Breastfed Infants.

    Change in intrahepatocellular lipid (IHCL) compared to breastfed infants, measured using in-vivo hepatic magnetic resonance spectroscopy

    Time frame: Between birth and 6-12 weeks age

07

Results

Posted Jun 7, 2019

Participant flow

Participants consisted of healthy, full term, appropriate weight-for-gestational age infants from 2 cohorts: recruited between November 1999 and October 2001 at the Hammersmith Hospital, and between March 2010 and May 2012 from the postnatal ward at Chelsea and Westminster Hospital.

Participant flow — Overall Study
MilestoneBreastfed InfantsMixed-fed InfantsFormula-fed Infants
Started80935
Completed36925
Not completed44010

Outcome measures

PrimaryChange in Total Adipose Tissue Volume

Difference in total adipose tissue volume, measured using whole body magnetic resonance imaging.

Time frame:
Between birth and 6-12 weeks age
Reported as:
Median · Litres
Change in Total Adipose Tissue Volume
LitresBreastfedMixed-fed InfantsFormula-fed Infants
Change in Total Adipose Tissue Volume0.718 (0.508 to 0.938)0.901 (0.452 to 1.053)0.775 (0.532 to 0.971)
SecondaryChange in Regional Adipose Tissue Distribution Compared to Breastfed Infants.

Change in regional adipose tissue distribution (ratio of internal abdominal to total subcutaneous abdominal adipose tissue) measured using whole body magnetic resonance imaging

Time frame:
Between birth and 6-12 weeks age
Reported as:
Median · no unit (ratio)
Change in Regional Adipose Tissue Distribution Compared to Breastfed Infants.
no unit (ratio)Breastfed InfantsMixed-fed InfantsFormula-fed Infants
Change in Regional Adipose Tissue Distribution Compared to Breastfed Infants.-0.07 (-0.09 to -0.02)-0.06 (-0.08 to -0.02)-0.03 (-0.07 to 0.01)
SecondaryChange in Intrahepatocellular Lipid Compared to Breastfed Infants.

Change in intrahepatocellular lipid (IHCL) compared to breastfed infants, measured using in-vivo hepatic magnetic resonance spectroscopy

Time frame:
Between birth and 6-12 weeks age
Reported as:
Median · ratio of CH2 to water
Change in Intrahepatocellular Lipid Compared to Breastfed Infants.
ratio of CH2 to waterBreastfed InfantsMixed-fed InfantsFormula-fed Infants
Change in Intrahepatocellular Lipid Compared to Breastfed Infants.1.192 (0.226 to 1.967)-0.054 (-.672 to 1.837)1.095 (-0.280 to 1.746)

Adverse events

Collected over 2 years and 2 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Breastfed Infants0/36 (0%)0/36 (0%)0/36 (0%)
Mixed-fed Infants0/9 (0%)0/9 (0%)0/9 (0%)
Formula-fed Infants0/25 (0%)0/25 (0%)0/25 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Breastfed InfantsMixed-fed InfantsFormula-fed InfantsTotal
<=18 years3692570
Between 18 and 65 years0000
>=65 years0000
Age, Continuous
Age, Continuous(Days)Breastfed InfantsMixed-fed InfantsFormula-fed InfantsTotal
Median13 (9 to 18)2 (1 to 10)16 (9 to 20)13 (9 to 17)
Sex: Female, Male
Sex: Female, Male(Participants)Breastfed InfantsMixed-fed InfantsFormula-fed InfantsTotal
Female1141530
Male2551040
Region of Enrollment
Region of Enrollment(participants)Breastfed InfantsMixed-fed InfantsFormula-fed InfantsTotal
United Kingdom3692570
Weight
Weight(kg)Breastfed InfantsMixed-fed InfantsFormula-fed InfantsTotal
Mean3.647 ± 0.4213.332 ± 0.4783.622 ± 0.5953.598 ± 0.500
Length
Length(m)Breastfed InfantsMixed-fed InfantsFormula-fed InfantsTotal
Mean0.533 ± 0.0230.510 ± 0.0250.523 ± 0.0250.527 ± 0.025
Head circumference
Head circumference(cm)Breastfed InfantsMixed-fed InfantsFormula-fed InfantsTotal
Mean36.5 ± 1.435.0 ± 1.736 ± 1.636.1 ± 1.6
Total adipose tissue
Total adipose tissue(l)Breastfed InfantsMixed-fed InfantsFormula-fed InfantsTotal
Median0.710 (0.632 to 0.899)0.802 (0.620 to 0.949)0.722 (0.613 to 0.913)0.718 (0.621 to 0.921)

10 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Chelsea and Westminster Hospital NHS Foundation Trust
    London, SW10 9NH, United Kingdom
09

References and documents

Publications

  • Gale C, Thomas EL, Jeffries S, Durighel G, Logan KM, Parkinson JR, Uthaya S, Santhakumaran S, Bell JD, Modi N. Adiposity and hepatic lipid in healthy full-term, breastfed, and formula-fed human infants: a prospective short-term longitudinal cohort study. Am J Clin Nutr. 2014 May;99(5):1034-40. doi: 10.3945/ajcn.113.080200. Epub 2014 Feb 26. Erratum In: Am J Clin Nutr. 2014 Oct;100(4):1213. PubMed 24572562 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02033005
Lead sponsor
Imperial College London
Collaborators
Chelsea and Westminster NHS Foundation Trust
Responsible party
Sponsor
First posted
Jan 10, 2014
Start date
Mar 2010
Primary completion
Jul 2012
Completion
Jul 2012
Results posted
Jun 7, 2019
Last update
Nov 15, 2022

Study contacts

Neena Modi, MBBS, MD
principal investigator · Imperial College London

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion